224 related articles for article (PubMed ID: 23308294)
1. The effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infection.
Wasil LR; Tomaszewski MJ; Hoji A; Rowe DT
PLoS One; 2013; 8(1):e54010. PubMed ID: 23308294
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation.
Price AM; Tourigny JP; Forte E; Salinas RE; Dave SS; Luftig MA
J Virol; 2012 Oct; 86(20):11096-106. PubMed ID: 22855490
[TBL] [Abstract][Full Text] [Related]
3. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.
Kaye KM; Izumi KM; Li H; Johannsen E; Davidson D; Longnecker R; Kieff E
J Virol; 1999 Dec; 73(12):10525-30. PubMed ID: 10559372
[TBL] [Abstract][Full Text] [Related]
4. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
Price AM; Messinger JE; Luftig MA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
[TBL] [Abstract][Full Text] [Related]
5. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.
Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W
mBio; 2019 Sep; 10(5):. PubMed ID: 31530670
[TBL] [Abstract][Full Text] [Related]
6. EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.
Guasparri I; Bubman D; Cesarman E
Blood; 2008 Apr; 111(7):3813-20. PubMed ID: 18230756
[TBL] [Abstract][Full Text] [Related]
7. In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2).
Rochford R; Miller CL; Cannon MJ; Izumi KM; Kieff E; Longnecker R
Arch Virol; 1997; 142(4):707-20. PubMed ID: 9170499
[TBL] [Abstract][Full Text] [Related]
8. Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.
Rechsteiner MP; Berger C; Zauner L; Sigrist JA; Weber M; Longnecker R; Bernasconi M; Nadal D
J Virol; 2008 Feb; 82(4):1739-47. PubMed ID: 18057232
[TBL] [Abstract][Full Text] [Related]
9. PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins.
Ikeda M; Ikeda A; Longnecker R
J Virol; 2001 Jun; 75(12):5711-8. PubMed ID: 11356981
[TBL] [Abstract][Full Text] [Related]
10. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.
Longnecker R; Miller CL; Miao XQ; Marchini A; Kieff E
J Virol; 1992 Nov; 66(11):6461-9. PubMed ID: 1328675
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
[TBL] [Abstract][Full Text] [Related]
12. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.
Vrazo AC; Chauchard M; Raab-Traub N; Longnecker R
PLoS Pathog; 2012; 8(4):e1002662. PubMed ID: 22536156
[TBL] [Abstract][Full Text] [Related]
14. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
Harada S; Yalamanchili R; Kieff E
J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
16. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.
Rowe M; Lear AL; Croom-Carter D; Davies AH; Rickinson AB
J Virol; 1992 Jan; 66(1):122-31. PubMed ID: 1309242
[TBL] [Abstract][Full Text] [Related]
17. Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.
Rechsteiner MP; Bernasconi M; Berger C; Nadal D
Trends Microbiol; 2008 Nov; 16(11):520-7. PubMed ID: 18835714
[TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB.
Izumi KM; Kieff ED
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12592-7. PubMed ID: 9356494
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
Brooks L; Yao QY; Rickinson AB; Young LS
J Virol; 1992 May; 66(5):2689-97. PubMed ID: 1313894
[TBL] [Abstract][Full Text] [Related]
20. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
